Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Zomedica Pharmaceuticals Corp (ZOMDF)

  • Business News
  • Jan. 23, 2026, 21:01 UTC
  • 0
  • 1 comments

Zomedica Expands its TRUVIEW(R) Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity

Market reaction Comment Full text

Erasca Inc (ERAS)

  • Business News
  • Jan. 23, 2026, 21:01 UTC
  • 0
  • 1 comments

Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Market reaction Comment Full text

Ocular Therapeutix Inc (OCUL)

  • Business News
  • Jan. 23, 2026, 21:01 UTC
  • 0
  • 1 comments

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Spyre Therapeutics (SYRE)

  • Business News
  • Jan. 23, 2026, 21:00 UTC
  • 0
  • 1 comments

Spyre Therapeutics Announces Grants of Inducement Awards

Market reaction Comment Full text

Integer Holdings Corp (ITGR)

  • Business News
  • Jan. 23, 2026, 20:30 UTC
  • 0
  • 1 comments

Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

agilon health Inc (AGL)

  • Business News
  • Jan. 23, 2026, 20:25 UTC
  • 0
  • 1 comments

agilon health, inc. (AGL) Shareholders Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text

Ultragenyx Pharmaceutical Inc (RARE)

  • Business News
  • Jan. 23, 2026, 19:05 UTC
  • 0
  • 1 comments

Ultragenyx Stock Declines After Missing Primary Endpoints on its Phase III Orbit and Cosmic Studies

Market reaction Comment Full text

AIM ImmunoTech Inc. (AIM)

  • Business News
  • Jan. 23, 2026, 18:22 UTC
  • 0
  • 1 comments

AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering

Market reaction Comment Full text

Daxor Corporation (DXR)

  • Business News
  • Jan. 23, 2026, 18:21 UTC
  • 0
  • 1 comments

Daxor Corporation Announces $9 Million Registered Direct Offering

Market reaction Comment Full text

National Research (NRC)

  • Business News
  • Jan. 23, 2026, 15:03 UTC
  • 0
  • 1 comments

Move the needle on reimbursement and patient experience | NRC Health Webcast

Market reaction Comment Full text
  • Previous
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Search

News categories

  • Technical Exchange News(10839)
  • Event(2204)
  • SEC News(187788)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124243)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin